Mode
Text Size
Log in / Sign up
N/A Completed N=114 Treatment

A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)

Source: ClinicalTrials.gov NCT00772707 ↗
Enrolled (actual)
114
Serious AEs
0.0%
Results posted
Sep 2012
Primary outcomePrimary: Comfort Ratings at Baseline — 86; 59; 57; 81 Percentage of Participants

Summary

The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-FREE RepleniSH®.

Outcome Measures

OutcomeResultp-value
PRIMARY
Comfort Ratings at Baseline
86; 59; 57; 81 —
PRIMARY
Comfort Ratings at 30 Days
92; 88; 91; 91; 71; 81 —

Eligibility Criteria

Inclusion Criteria

  • Participants must be between 18 and 65 years of age.
  • Must wear daily wear soft contact lenses a minimum of 8 hours per day,7 days a week.
  • Must be wearing a planned replacement soft lens in a 2 week or monthly replacement modality.
  • Must be using either COMPLETE Multi-Purpose Solution (MPS) Easy Rub or ReNu MultiPlus brand solution for at least 30 continuous days prior to enrollment.
  • Must be free of any contact lens-related symptoms with regard to comfort and vision throughout their wearing hours prior to enrollment, with the exception of end-of-day dryness not limiting all day wear.
  • Must have best corrected distance visual acuity, with contact lenses, of 20/30 or better in each eye.
  • Must be willing to maintain pre-enrollment systemic medication regimens during the study.
  • Must be willing to not use any topical medications or rewetting drops during the 30 day clinical trial duration.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • Has used any topical medication or rewetting drops for 7 days prior to enrollment.
  • Achieves best visual correction by monovision.
  • Has modified their systemic medications within 30 days prior to enrollment.
  • Has switched brands of cosmetics during the 30 days prior to the study.
  • Has a history of allergy to any study product ingredients.
  • Is unwilling or unable to meet the study visit timeline.
  • Has any active corneal, eyelid or other anterior segment inflammation or infection, which, in the opinion of the Investigator, would adversely affect successful contact lens wear.
  • Other protocol-defined exclusion criteria may apply.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00772707). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search